ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 142 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 624,768 | $29,533,000 | 9.76% |
| Fairmount Funds Management LLC | 469,264 | $22,182,000 | 5.08% |
| Foresite Capital Opportunity Management V, LLC | 22,750 | $1,075,000 | 2.71% |
| ARMISTICE CAPITAL, LLC | 2,070,000 | $97,849,000 | 1.71% |
| Paradigm Biocapital Advisors LP | 148,216 | $7,006,000 | 1.40% |
| Foresite Capital Management V, LLC | 42,250 | $1,997,000 | 1.40% |
| RA Capital Management | 896,724 | $42,389,000 | 1.13% |
| TANG CAPITAL MANAGEMENT LLC | 137,700 | $6,509,000 | 0.99% |
| Soleus Capital Management, L.P. | 100,000 | $4,727,000 | 0.74% |
| ACUTA CAPITAL PARTNERS, LLC | 27,500 | $1,300,000 | 0.72% |